• ABOUT
    SUNHAWK VISION

Mission
Develop new drugs and medical equipment to treat eye diseases and to maintain good eyesight.
Vision
Create innovative ophthalmic products to protect your eyesight
Story
In the early research stage, the core team received both financial and administrative supports from the Taiwan Ministry of Science and Technology. The team developed the proprietary technology for novel anti-myopia eye drops. With the assistance from Taiwan Startup Institute, the team established Sunhawk Vision Biotech, Inc. in August 2019. The Company facilitates the translation of early R&D results to final ophthalmic products. The anti-myopia eye drop is planned to enter human clinical trials to confirm its safety and effectiveness. It is expected that the novel anti-myopia medication will successfully move to the NDA stage and enter the Asian market as well as global market.

  • FOUNDER
    INTRODUCTION
The Chairman, Dr. Chung-Ling (Christine) Liang, received both her medical and PhD degrees from the Chang Gung University in Taiwan. She is a board-certified ophthalmologist in Taiwan. She was also trained in pediatric ophthalmology as her sub-specialty in the Massachusetts Eye and Ear Infirmary (MEEI)/Harvard Medical School. Dr. Liang served as a senior attending physician at Chang Gung Hospital and Department Chief at Kaohsiung Municipal Hospital. She is the founding Chair of Department of Ophthalmology at Asian University Hospital. She is an associate professor and currently is the Medical Director at Bright Eyes Clinics in Kaohsiung City, Taiwan.
  • Dr. Liang
Dr. Suh-Hang Hank Juo is the key inventor of the novel anti-myopia eye drops. He received MD degree from the Kaohsiung Medical University, MS degree from the Harvard University and PhD degree from the Johns Hopkins University. Dr. Suh-Hang Hank Juo finished his post-doc fellowships at Rockefeller University and National Institutes of Health (NIH) USA. He was appointed as an assistant professor and then associate professor at Columbia University. He is an internationally known human geneticist and a board-certified neurologist. He has published more than 180 peer-reviewed SCI papers with citation times more than 5800. He received many awards domestically and internationally. Currently, he is a distinguished professor at the China Medical University in Taiwan.
  • Dr. Hank Juo
  • AWARDS
Future technology award
Public outreach award
Public outreach award
National innovation award
National innovation award
Future technology award
Outstanding research award
Outstanding research award
Future technology award
Break Out and Soar High Award
  • RESEARCH
  • myopia genetic studies
    link to recommended research articles
    more
    +
  • studies of myopia control
    link to recommended research articles
    more
    +